APA (7th ed.) Citation

Ferreira, R. Q., Monteiro, C. B., Dias, A. C., Abreu, F., Darmits, B., Oura, M. J., . . . Simão, D. C. (2026). Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study. European Journal of Breast Health, 22(3), 318. https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3

Chicago Style (17th ed.) Citation

Ferreira, Rita Quaresma, et al. "Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study." European Journal of Breast Health 22, no. 3 (2026): 318. https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3.

MLA (9th ed.) Citation

Ferreira, Rita Quaresma, et al. "Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study." European Journal of Breast Health, vol. 22, no. 3, 2026, p. 318, https://doi.org/10.4274/ejbh.galenos.2026.2026-2-3.